MAPT and Alzheimer disease: In the brain, excessive activation of GSK3β promotes abnormal hyper phosphorylation of tau protein, aggravates degeneration of neurons, interferes with normal synaptic plasticity, and accelerates AD pathology process in AD patients [22].